PFE lags the market as COVID sales drop and patent losses loom, but new drugs and cost cuts may fuel a comeback.

Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

CureVac (CVAC) stock jumps as BioNTech (BNTX) agrees to acquire in an all-stock deal worth $1.25B. Read more here.

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

According to TipRanks.com, Huynh is a 5-star analyst with an average return of 13.3% and a 68.9% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Acumen Pharmaceuticals, ...